Blue Jay Gold Reports 67% Antimony Concentrate at 94% Recovery from Becker-Cochran: Concentrates Submitted for Metal Refining Tests

Blue Jay Gold produced a 66.9% antimony concentrate with 93.9% recovery from preliminary bench-scale flotation testing of Becker-Cochran material at its Steller project, exceeding the 60% Sb premium-product threshold. Approximately 50 kg of concentrate has been sent to three North American processors for conversion into finished antimony products, with initial results expected within weeks. The result supports potential critical-minerals upside at Steller, though it is based on a single 2.0 kg composite test, lacks variability and locked-cycle studies, and does not yet represent a commercial process design or offtake arrangement.

Analysis

The relevant valuation question is not metallurgical quality but whether Blue Jay can establish mineable continuity, payable terms, and a financeable development path. A surface-selected composite can materially overstate run-of-mine economics; mercury deportment, concentrate penalties, variability, dilution, and logistics are the variables that determine whether an apparent premium concentrate earns a premium netback. Until these are resolved, the antimony occurrence should be assigned option value rather than a resource-based NAV uplift.

Near-term retail interest could expand JAY's critical-minerals multiple, particularly because North American supply security commands a scarcity premium. That premium is fragile: processor samples are neither binding offtake nor proof of commercial-scale refining capacity, and junior-explorer liquidity can reverse sharply if pending drilling fails to demonstrate width and depth continuity. The more important 6-18 month implication is strategic optionality: credible domestic antimony feed could make the asset relevant to processors or government-backed supply-chain programs, but only after representative drilling, locked-cycle tests, impurity characterization, and a preliminary economic framework.

The contrarian view is that the market may capitalize a strategic-metal narrative before the project has solved its principal geological and commercial risks. For listed antimony exposure, established North American development optionality such as PPTA is likely to receive institutional flows first because it has a more advanced permitting and financing pathway; JAY remains a high-beta exploration catalyst vehicle rather than a substitute for producible supply.

Key Decisions for Investors

• No core position in JAY/JAYGF at current disclosure stage; place on a catalyst watchlist for the next 1-3 months. Upgrade only if drill results demonstrate continuous, economically meaningful mineralization and downstream testing discloses mercury treatment, payable assumptions, and commercial product specifications.
• For antimony-theme exposure, prefer a small long PPTA position over JAY on a 6-18 month horizon; PPTA offers more direct leverage to a permitted North American critical-minerals development pathway. Reassess if permitting, funding, or construction milestones slip, or if antimony pricing weakens enough to impair projected by-product economics.
• If JAY rallies materially on processor-sample headlines without a resource estimate or binding offtake, consider a tactical short-term fade or avoid chasing liquidity-driven gains. Thesis is falsified by independently disclosed commercial terms, representative variability results, and drill-supported scale sufficient to support a resource.
• Monitor Canadian and U.S. critical-minerals funding announcements and antimony trade-policy actions over the next 3-6 months. A government-backed processing or offtake framework would be the clearest catalyst for a re-rating across JAY, PPTA, and UAMY; absent that, junior-explorer financing risk remains the dominant constraint.